Background: Retinal edema is the major complication of retinal vein occlusion and diabetic retinopathy; it can damage visual function by influencing macular region. This study was to establish a rat retinal edema model and explore the related VEGF expression and observe the responses to anti-VEGF drugs in this model. Methods: A rat retinal edema model was established by inducing photochemical reaction using a 532 nm laser after the intravenous injection of Erythrosin B. Immediately after the laser treatment, models were given intravitreal injections of Ranibizumab or Conbercept to inhibit VEGF expression, and the changes of retinal thickness were measured. Retinal edema was observed using fundus photography (FP), optical coherence tomograph...
Vascular endothelial growth factor (VEGF) is a major therapeutic target for blood–retina barrier (BR...
Purpose: Plasma kallikrein is a serine protease and circulating component of inflammation, which exe...
In this study, we characterized diabetic retinopathy in two mouse models and the response to anti-va...
<p><strong>Aim.</strong> To describe the dynamics of vascular endothelial growth factor (VEGF) immun...
AIMS/HYPOTHESIS: Vascular endothelial growth factor (VEGF) plays a pivotal role in the pathogenesis ...
AIM:To investigate the natural course and adverse event of branch retinal vein occlusion(BRVO)rat mo...
Purpose: To investigate the mechanism of soluble vascular adhesion protein-1 (sVAP-1) accumulation i...
To establish an animal model of retinal neovascularization using vascular endothelial growth factor ...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
AIM:To establish the rat model of streptozotocin (STZ)-induced diabetic retinopathy (DR), which is t...
Diabetic retinopathy (DR) is a complication of diabetes that can ultimately lead to vision loss. Ear...
Vascular endothelial growth factor (VEGF) is a major therapeutic target for blood–retina barrier (BR...
Purpose: Plasma kallikrein is a serine protease and circulating component of inflammation, which exe...
In this study, we characterized diabetic retinopathy in two mouse models and the response to anti-va...
<p><strong>Aim.</strong> To describe the dynamics of vascular endothelial growth factor (VEGF) immun...
AIMS/HYPOTHESIS: Vascular endothelial growth factor (VEGF) plays a pivotal role in the pathogenesis ...
AIM:To investigate the natural course and adverse event of branch retinal vein occlusion(BRVO)rat mo...
Purpose: To investigate the mechanism of soluble vascular adhesion protein-1 (sVAP-1) accumulation i...
To establish an animal model of retinal neovascularization using vascular endothelial growth factor ...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion...
AIM:To establish the rat model of streptozotocin (STZ)-induced diabetic retinopathy (DR), which is t...
Diabetic retinopathy (DR) is a complication of diabetes that can ultimately lead to vision loss. Ear...
Vascular endothelial growth factor (VEGF) is a major therapeutic target for blood–retina barrier (BR...
Purpose: Plasma kallikrein is a serine protease and circulating component of inflammation, which exe...
In this study, we characterized diabetic retinopathy in two mouse models and the response to anti-va...